Interferon gamma ELISPOT testing as a risk-stratifying biomarker for kidney transplant injury: Results from the CTOT-01 multicenter study

American Journal of Transplantation

Volumn 15, Issue 12, 2015, Pages 3166-3173

  Hricik, D E ^a   Augustine, J ^a   Nickerson, P ^b   Formica, R N ^c   Poggio, E D ^d   Rush, D ^b   Newell, K A ^e   Goebel, J ^f   Gibson, I W ^b   Fairchild, R L ^d   Spain, K ^g   Ikle D ^g   Bridges, N D ^h   Heeger, P S ⁱ  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g Rho   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; CREATININE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; THYMOCYTE ANTIBODY; LYMPHOCYTE ANTIBODY;

ADULT; AFRICAN AMERICAN; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; GAMMA INTERFERON ENZYME LINKED IMMUNOSPOT ASSAY; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; URINALYSIS; ADVERSE EFFECTS; ANIMAL; CHILD; CLINICAL TRIAL; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; PROGNOSIS; RABBIT; RISK FACTOR;

ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; BIOMARKERS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERFERON-GAMMA; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RABBITS; RISK FACTORS; TISSUE DONORS;

EID: 84948695640     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13401     Document Type: Article

References (23)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B,. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
2. Gebauer BS, Hricik DE, Atallah A, et al., Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2: 857-866.
3. Reinsmoen NL, Cornett KM, Kloehn R, et al., Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection. Transplantation 2008; 85: 462-470.
4. Tary-Lehmann M, Hricik DE, Justice AC, Potter NS, Heeger PS,. Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure. Transplantation 1998; 66: 219-224.
5. Valujskikh A, Pantenburg B, Heeger PS,. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002; 2: 501-509.
6. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al., Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
7. Augustine JJ, Siu DS, Clemente MJ, Schulak JA, Heeger PS, Hricik DE,. Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 2005; 5: 1971-1975.
8. Hricik DE, Rodriguez V, Riley J, et al., Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003; 3: 878-884.
9. Bestard O, Cruzado JM, Lucia M, et al., Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation. Kidney Int 2013; 84: 1226-1236.
10. Kim SH, Oh EJ, Kim MJ, et al., Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients. Transplant Proc 2007; 39: 3057-3060.
11. Koscielska-Kasprzak K, Drulis-Fajdasz D, Kaminska D, et al., Pretransplantation cellular alloreactivity is predictive of acute graft rejection and 1-year graft function in kidney transplant recipients. Transplant Proc 2009; 41: 3006-3008.
12. Nather BJ, Nickel P, Bold G, et al., Modified ELISPOT technique-highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Transplant Immunol 2006; 16: 232-237.
13. Nickel P, Presber F, Bold G, et al., Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 2004; 78: 1640-1646.
14. Hricik DE, Nickerson P, Formica RN, et al., Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant 2013; 13: 2634-2644.
15. Ashoor I, Najafian N, Korin Y, et al., Standardization and cross validation of alloreactive IFNgamma ELISPOT assays within the clinical trials in organ transplantation consortium. Am J Transplant 2013; 13: 1871-1879.
16. Zand MS, Bose A, Vo T, et al., A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity. Am J Transplant 2005; 5: 76-86.
17. Levey AS, Coresh J, Greene T, et al., Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
18. Schwartz GJ, Munoz A, Schneider MF, et al., New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
19. Gurkan S, Luan Y, Dhillon N, et al., Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010; 10: 2132-2141.
20. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D,. Thymoglobulin Induction Study G. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967-1977.
21. Augustine JJ, Poggio ED, Heeger PS, Hricik DE,. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots. Transplantation 2008; 86: 529-534.
22. Pearl JP, Parris J, Hale DA, et al., Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465-474.
23. Tchao NK, Turka LA,. Lymphodepletion and homeostatic proliferation: Implications for transplantation. Am J Transplant 2012; 12: 1079-1090.